CF PharmTech, Inc. (stock code 02652) disclosed that on 4 February 2026, 8,500 ordinary shares were repurchased at a volume-weighted average price of HKD 34.7706. The repurchased shares represent approximately 0.0028% of the total number of issued shares (excluding treasury shares) as of the preceding day.

Following this repurchase, the company recorded 302,022,586 issued shares (excluding treasury shares) and a total of 201,000 treasury shares as of 4 February 2026. The aggregate price paid for the 8,500 repurchased shares amounted to HKD 295,550. The repurchase was executed in accordance with the previously granted mandate dated 16 December 2025, under which up to 30,222,358 shares were authorized for repurchase.